michaelweirsky| Yiyatong: Its Shenzhen Pharmaceutical Holdings has reached strategic cooperation with Liaoning Pharmaceutical Alliance Pharmaceutical

News summary

[Yiyatong: Its subsidiary Shenzhen Pharmaceutical Holdings has reached strategic cooperation with Liaoning Pharmaceutical Alliance Pharmaceutical] Securities Times e Company NewsmichaelweirskyOn May 21, the digital medical platform Shenzhen Pharmaceutical Holdings (Liaoning) Co., Ltd.(referred to as Shenzhen Pharmaceutical Holdings) and Liaoning Pharmaceutical Co., Ltd.(referred to as Liaoning Pharmaceutical Co., Ltd.michaelweirsky...

Newsletter text

[Yiyatong: Its Shenzhen Pharmaceutical Holdings and Liaoning Pharmaceutical have reached a strategic cooperation] Securities Times e Company News, on May 21, Shenzhen Pharmaceutical Holdings (Liaoning) Co., Ltd.(referred to as Shenzhen Pharmaceutical Holdings), a digital medical platform owned by Yiyatong, and Liaoning Pharmaceutical Co., Ltd.(referred to as Liaoning Pharmaceutical) held a strategic cooperation signing ceremony. In future cooperation, Shenyao Holdings will become the exclusive distributor of potassium aspartate injection in China, responsible for the national distribution of the agreed product (in 2023, the annual sales of this product in China will be approximately 180 million yuan), and the two parties also agreed to carry out further collaboration in strategic cooperation, market expansion, and joint construction of nutrition departments.